Search Results - Michael Cecchini

Olaparib in treatment‐refractory isocitrate dehydrogenase 1 (IDH1)– and IDH2‐mutant cholangiocarcinoma: Safety and antitumor activity from the phase 2 National Cancer Institute 101... Autoría: Michael Cecchini, Mary Jo Pilat, Nataliya Uboha, Nilofer S. Azad, May Cho, Elizabeth J. Davis, Jordi Rodon Ahnert, Gabriel Tinoco, Geoffrey I. Shapiro, Simon Khagi, Benjamin Powers, Kristen Spencer, Roman Groisberg, Jan Drappatz, Li Chen, Biswajit Das, Xun Bao, Jing Li, Azeet Narayan, Dennis Vu, Abhijit Patel, Monica Niger, Deborah Doroshow, Diane Durecki, Scott A. Boerner, Ranjit Bindra, Percy Ivy, Derek Shyr, Yu Shyr, Patricia M. LoRusso